Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Neuropeptides ; 47(1): 37-41, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23009720

ABSTRACT

Previous data from our labs and from others have demonstrated that intracerebroventricular (ICV) injection of alarin has orexigenic activity and significantly increases plasma luteinizing hormone (LH) secretion in a gonadotropin-releasing hormone (GnRH) dependent manner. The purpose of the current experiments was to determine if the amino acids at the amino-terminal end of the alarin peptide are critical for alarin's effects on reproductive and feeding systems. First, we injected male mice ICV with full-length alarin (Ala1-25) or peptide fragments missing residues at the amino-terminal end (Ala3-25 or Ala6-25 Cys). Neither peptide fragment alone, significantly increased food intake in male mice compared to controls. Second, ICV injection of Ala1-25, but not Ala3-25, significantly (p < 0.01) increased GnRH-mediated LH secretion. Surprisingly, Ala6-25 Cys significantly (p < 0.05) inhibited plasma LH secretion and inhibited Ala1-25 actions. In conclusion, elimination of the first five amino acids of alarin not only abolishes the biological activity of alarin, but becomes an antagonist to alarin-specific effects. Furthermore, Ala6-25 Cys seems to act as a specific antagonist to putative alarin receptors and therefore may be an important tool in identifying alarin-specific receptors.


Subject(s)
Eating/drug effects , Galanin-Like Peptide/antagonists & inhibitors , Galanin-Like Peptide/pharmacology , Luteinizing Hormone/metabolism , Peptide Fragments/pharmacology , Animals , Body Temperature/drug effects , Body Weight/drug effects , Brain Chemistry/drug effects , Gonadotropin-Releasing Hormone/physiology , Injections, Intraventricular , Male , Mice , Mice, Inbred C57BL , Telemetry
SELECTION OF CITATIONS
SEARCH DETAIL
...